Report Detail

Pharma & Healthcare Global and United States Injection Influenza Vaccine Market Report & Forecast 2022-2028

  • RnM4421315
  • |
  • 09 April, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Summary:

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Analysis and Insights: Global and United States Injection Influenza Vaccine Market
This report focuses on global and United States Injection Influenza Vaccine market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Injection Influenza Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Trivalent Influenza Vaccine accounting for % of the Injection Influenza Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, 6 Months to 3 Years was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Injection Influenza Vaccine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Injection Influenza Vaccine Scope and Market Size
Injection Influenza Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Injection Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Injection Influenza Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Injection Influenza Vaccine market is segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application, the Injection Influenza Vaccine market is segmented into
6 Months to 3 Years
> 3 Years
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Injection Influenza Vaccine Market Share Analysis
Injection Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Injection Influenza Vaccine business, the date to enter into the Injection Influenza Vaccine market, Injection Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics


Table of Contents

    1 Study Coverage

    • 1.1 Injection Influenza Vaccine Product Introduction
    • 1.2 Global Injection Influenza Vaccine Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Injection Influenza Vaccine Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Injection Influenza Vaccine Sales in Volume for the Year 2017-2028
    • 1.3 United States Injection Influenza Vaccine Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Injection Influenza Vaccine Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Injection Influenza Vaccine Sales in Volume for the Year 2017-2028
    • 1.4 Injection Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Injection Influenza Vaccine in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Injection Influenza Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Injection Influenza Vaccine Market Dynamics
      • 1.5.1 Injection Influenza Vaccine Industry Trends
      • 1.5.2 Injection Influenza Vaccine Market Drivers
      • 1.5.3 Injection Influenza Vaccine Market Challenges
      • 1.5.4 Injection Influenza Vaccine Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Injection Influenza Vaccine Market Segment by Type
      • 2.1.1 Trivalent Influenza Vaccine
      • 2.1.2 Quadrivalent Influenza Vaccine
    • 2.2 Global Injection Influenza Vaccine Market Size by Type
      • 2.2.1 Global Injection Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Injection Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Injection Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Injection Influenza Vaccine Market Size by Type
      • 2.3.1 United States Injection Influenza Vaccine Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Injection Influenza Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Injection Influenza Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Injection Influenza Vaccine Market Segment by Application
      • 3.1.1 6 Months to 3 Years
      • 3.1.2 > 3 Years
    • 3.2 Global Injection Influenza Vaccine Market Size by Application
      • 3.2.1 Global Injection Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Injection Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Injection Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Injection Influenza Vaccine Market Size by Application
      • 3.3.1 United States Injection Influenza Vaccine Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Injection Influenza Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Injection Influenza Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Injection Influenza Vaccine Competitor Landscape by Company

    • 4.1 Global Injection Influenza Vaccine Market Size by Company
      • 4.1.1 Top Global Injection Influenza Vaccine Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Injection Influenza Vaccine Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Injection Influenza Vaccine Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Injection Influenza Vaccine Price by Manufacturer (2017-2022)
    • 4.2 Global Injection Influenza Vaccine Concentration Ratio (CR)
      • 4.2.1 Injection Influenza Vaccine Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Injection Influenza Vaccine in 2021
      • 4.2.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Injection Influenza Vaccine Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Injection Influenza Vaccine Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Injection Influenza Vaccine Product Type
      • 4.3.3 Date of International Manufacturers Enter into Injection Influenza Vaccine Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Injection Influenza Vaccine Market Size by Company
      • 4.5.1 Top Injection Influenza Vaccine Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Injection Influenza Vaccine Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Injection Influenza Vaccine Sales by Players (2020, 2021 & 2022)

    5 Global Injection Influenza Vaccine Market Size by Region

    • 5.1 Global Injection Influenza Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Injection Influenza Vaccine Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Injection Influenza Vaccine Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Injection Influenza Vaccine Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Injection Influenza Vaccine Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Injection Influenza Vaccine Sales in Value by Region: 2017-2022
      • 5.3.2 Global Injection Influenza Vaccine Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Injection Influenza Vaccine Market Size YoY Growth 2017-2028
      • 6.1.2 North America Injection Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Injection Influenza Vaccine Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Injection Influenza Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Injection Influenza Vaccine Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Injection Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Injection Influenza Vaccine Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Injection Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Injection Influenza Vaccine Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Sanofi
      • 7.1.1 Sanofi Corporation Information
      • 7.1.2 Sanofi Description and Business Overview
      • 7.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Sanofi Injection Influenza Vaccine Products Offered
      • 7.1.5 Sanofi Recent Development
    • 7.2 CSL
      • 7.2.1 CSL Corporation Information
      • 7.2.2 CSL Description and Business Overview
      • 7.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 CSL Injection Influenza Vaccine Products Offered
      • 7.2.5 CSL Recent Development
    • 7.3 GSK
      • 7.3.1 GSK Corporation Information
      • 7.3.2 GSK Description and Business Overview
      • 7.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 GSK Injection Influenza Vaccine Products Offered
      • 7.3.5 GSK Recent Development
    • 7.4 Viatris
      • 7.4.1 Viatris Corporation Information
      • 7.4.2 Viatris Description and Business Overview
      • 7.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Viatris Injection Influenza Vaccine Products Offered
      • 7.4.5 Viatris Recent Development
    • 7.5 AstraZeneca
      • 7.5.1 AstraZeneca Corporation Information
      • 7.5.2 AstraZeneca Description and Business Overview
      • 7.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 AstraZeneca Injection Influenza Vaccine Products Offered
      • 7.5.5 AstraZeneca Recent Development
    • 7.6 Hualan Bio
      • 7.6.1 Hualan Bio Corporation Information
      • 7.6.2 Hualan Bio Description and Business Overview
      • 7.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Hualan Bio Injection Influenza Vaccine Products Offered
      • 7.6.5 Hualan Bio Recent Development
    • 7.7 Changchun Institute of Biological
      • 7.7.1 Changchun Institute of Biological Corporation Information
      • 7.7.2 Changchun Institute of Biological Description and Business Overview
      • 7.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Changchun Institute of Biological Injection Influenza Vaccine Products Offered
      • 7.7.5 Changchun Institute of Biological Recent Development
    • 7.8 Sinovac
      • 7.8.1 Sinovac Corporation Information
      • 7.8.2 Sinovac Description and Business Overview
      • 7.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Sinovac Injection Influenza Vaccine Products Offered
      • 7.8.5 Sinovac Recent Development
    • 7.9 Jiangsu GDK
      • 7.9.1 Jiangsu GDK Corporation Information
      • 7.9.2 Jiangsu GDK Description and Business Overview
      • 7.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Jiangsu GDK Injection Influenza Vaccine Products Offered
      • 7.9.5 Jiangsu GDK Recent Development
    • 7.10 KM Biologics
      • 7.10.1 KM Biologics Corporation Information
      • 7.10.2 KM Biologics Description and Business Overview
      • 7.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 KM Biologics Injection Influenza Vaccine Products Offered
      • 7.10.5 KM Biologics Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Injection Influenza Vaccine Industry Chain Analysis
    • 8.2 Injection Influenza Vaccine Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Injection Influenza Vaccine Distributors
    • 8.3 Injection Influenza Vaccine Production Mode & Process
    • 8.4 Injection Influenza Vaccine Sales and Marketing
      • 8.4.1 Injection Influenza Vaccine Sales Channels
      • 8.4.2 Injection Influenza Vaccine Distributors
    • 8.5 Injection Influenza Vaccine Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Injection Influenza Vaccine. Industry analysis & Market Report on Injection Influenza Vaccine is a syndicated market report, published as Global and United States Injection Influenza Vaccine Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Injection Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,076.15
      6,152.30
      3,576.65
      7,153.30
      595,056.00
      1,190,112.00
      321,475.00
      642,950.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report